which glp 1 is approved for weight loss GLP-1s Loss: What You Need to Know Poll: 1 in 8 Adults

The conversation covers how our understanding of obesity as a chronic, relapsing disease has changed over the past 30 years, what the new clinical versus preclinical obesity framework means for how we diagnose and treat it, how GLP-1 drugs work and why they've succeeded where earlier medications failed, what the STEP and SELECT trials revealed about the disease-modifying potential of semaglutide, and how patients and clinicians should be thinking about who these drugs are really for

For example, the SELECT trial clearly demonstrated that semaglutide significantly reduces the risk of major adverse cardiovascular events (MACE), leading to FDA approval for lowering the risk of cardiovascular death, myocardial infarction, or stroke in overweight or obese adults with established cardiovascular disease (Lincoff et al., 2023

This is imped widespread acceptance among regulators and healthcare providers

During T2D development, chronic overnutrition interferes with insulin signaling leading to decreases in insulin sensitivity

It is a key player in Phase II Conjugation in the liver: Binding Toxins: Glutathione binds to fat-soluble toxins, heavy metals (like mercury and lead), and metabolic waste, transforming them into water-soluble compounds that can be easily excreted